Studies have shown that peroxisome gamma coactivator-1β (PGC-1β) is negatively correlated with FOXA2 expression in breast cancer, but PGC-1β binds to FOXA2 to decrease FOXA2 expression in breast cancer and induces EMT [118]. This evidence concerns the gene PPARGC1B and breast carcinoma.